Analysis  ||| S:0 E:9 ||| NN
on  ||| S:9 E:12 ||| IN
clinical  ||| S:12 E:21 ||| JJ
and  ||| S:21 E:25 ||| CC
epidemioloical  ||| S:25 E:40 ||| JJ
characteristics  ||| S:40 E:56 ||| NNS
of  ||| S:56 E:59 ||| IN
measles  ||| S:59 E:67 ||| NN
in  ||| S:67 E:70 ||| IN
hospitalized  ||| S:70 E:83 ||| JJ
children  ||| S:83 E:92 ||| NNS
in  ||| S:92 E:95 ||| IN
Shanghai  ||| S:95 E:104 ||| NNP
in  ||| S:104 E:107 ||| IN
2012  ||| S:107 E:112 ||| CD
To  ||| S:112 E:115 ||| TO
investigate  ||| S:115 E:127 ||| VB
the  ||| S:127 E:131 ||| DT
main  ||| S:131 E:136 ||| JJ
factors  ||| S:136 E:144 ||| NNS
that  ||| S:144 E:149 ||| WDT
influence  ||| S:149 E:159 ||| VBP
measles  ||| S:159 E:167 ||| JJ
morbidity  ||| S:167 E:177 ||| NN
and  ||| S:177 E:181 ||| CC
the  ||| S:181 E:185 ||| DT
genotype  ||| S:185 E:194 ||| NN
of  ||| S:194 E:197 ||| IN
measles  ||| S:197 E:205 ||| JJ
virus ||| S:205 E:210 ||| NN
,  ||| S:210 E:212 ||| ,
so  ||| S:212 E:215 ||| RB
as  ||| S:215 E:218 ||| RB
to  ||| S:218 E:221 ||| TO
provide  ||| S:221 E:229 ||| VB
evidence  ||| S:229 E:238 ||| NN
for  ||| S:238 E:242 ||| IN
scientific  ||| S:242 E:253 ||| JJ
decision  ||| S:253 E:262 ||| NN
making  ||| S:262 E:269 ||| VBG
to  ||| S:269 E:272 ||| TO
further  ||| S:272 E:280 ||| RB
control  ||| S:280 E:288 ||| VB
the  ||| S:288 E:292 ||| DT
prevalence  ||| S:292 E:303 ||| NN
of  ||| S:303 E:306 ||| IN
measles ||| S:306 E:313 ||| NN
.  ||| S:313 E:315 ||| .
A  ||| S:315 E:317 ||| DT
retrospective  ||| S:317 E:331 ||| JJ
analysis  ||| S:331 E:340 ||| NN
included  ||| S:340 E:349 ||| VBD
182  ||| S:349 E:353 ||| CD
children  ||| S:353 E:362 ||| NNS
in  ||| S:362 E:365 ||| IN
Children ||| S:365 E:373 ||| NNP
's  ||| S:373 E:376 ||| POS
Hospital  ||| S:376 E:385 ||| NN
of  ||| S:385 E:388 ||| IN
Fudan  ||| S:388 E:394 ||| NNP
University ||| S:394 E:404 ||| NNP
,  ||| S:404 E:406 ||| ,
diagnosed  ||| S:406 E:416 ||| VBN
with  ||| S:416 E:421 ||| IN
measles  ||| S:421 E:429 ||| NN
from  ||| S:429 E:434 ||| IN
January  ||| S:434 E:442 ||| NNP
1 ||| S:442 E:443 ||| CD
,  ||| S:443 E:445 ||| ,
2012  ||| S:445 E:450 ||| CD
to  ||| S:450 E:453 ||| TO
December  ||| S:453 E:462 ||| NNP
31 ||| S:462 E:464 ||| CD
.  ||| S:464 E:466 ||| .
The  ||| S:466 E:470 ||| DT
clinical  ||| S:470 E:479 ||| JJ
and  ||| S:479 E:483 ||| CC
epidemiological  ||| S:483 E:499 ||| JJ
characteristics ||| S:499 E:514 ||| NNS
,  ||| S:514 E:516 ||| ,
including  ||| S:516 E:526 ||| VBG
the  ||| S:526 E:530 ||| DT
gender ||| S:530 E:536 ||| NN
,  ||| S:536 E:538 ||| ,
age ||| S:538 E:541 ||| NN
,  ||| S:541 E:543 ||| ,
the  ||| S:543 E:547 ||| DT
incidence  ||| S:547 E:557 ||| NN
of  ||| S:557 E:560 ||| IN
seasonal  ||| S:560 E:569 ||| JJ
trends ||| S:569 E:575 ||| NNS
,  ||| S:575 E:577 ||| ,
measles  ||| S:577 E:585 ||| JJ
vaccine  ||| S:585 E:593 ||| NN
vaccination  ||| S:593 E:605 ||| NN
history ||| S:605 E:612 ||| NN
,  ||| S:612 E:614 ||| ,
contact  ||| S:614 E:622 ||| NN
history  ||| S:622 E:630 ||| NN
and  ||| S:630 E:634 ||| CC
other  ||| S:634 E:640 ||| JJ
clinical  ||| S:640 E:649 ||| JJ
manifestations ||| S:649 E:663 ||| NNS
,  ||| S:663 E:665 ||| ,
laboratory  ||| S:665 E:676 ||| NN
test  ||| S:676 E:681 ||| NN
results ||| S:681 E:688 ||| NNS
,  ||| S:688 E:690 ||| ,
and  ||| S:690 E:694 ||| CC
so  ||| S:694 E:697 ||| RB
on  ||| S:697 E:700 ||| IN
were  ||| S:700 E:705 ||| VBD
analyzed ||| S:705 E:713 ||| VBN
.  ||| S:713 E:715 ||| .
And  ||| S:715 E:719 ||| CC
the  ||| S:719 E:723 ||| DT
reverse  ||| S:723 E:731 ||| JJ
transcription  ||| S:731 E:745 ||| JJ
PCR  ||| S:745 E:749 ||| NNP
( ||| S:749 E:750 ||| -LRB-
RT-PCR ||| S:750 E:756 ||| NNP
)  ||| S:756 E:758 ||| -RRB-
was  ||| S:758 E:762 ||| VBD
adopted  ||| S:762 E:770 ||| VBN
to  ||| S:770 E:773 ||| TO
detect  ||| S:773 E:780 ||| VB
sputum  ||| S:780 E:787 ||| JJ
specimens  ||| S:787 E:797 ||| NNS
from  ||| S:797 E:802 ||| IN
suspected  ||| S:802 E:812 ||| JJ
patients  ||| S:812 E:821 ||| NNS
with  ||| S:821 E:826 ||| IN
measles ||| S:826 E:833 ||| NN
, ||| S:833 E:834 ||| ,
who  ||| S:834 E:838 ||| WP
were  ||| S:838 E:843 ||| VBD
selected  ||| S:843 E:852 ||| VBN
randomly ||| S:852 E:860 ||| RB
, ||| S:860 E:861 ||| ,
the  ||| S:861 E:865 ||| DT
sequence  ||| S:865 E:874 ||| NN
of  ||| S:874 E:877 ||| IN
the  ||| S:877 E:881 ||| DT
part  ||| S:881 E:886 ||| NN
of  ||| S:886 E:889 ||| IN
the  ||| S:889 E:893 ||| DT
PCR  ||| S:893 E:897 ||| NNP
products  ||| S:897 E:906 ||| NNS
was  ||| S:906 E:910 ||| VBD
analyzed.  ||| S:910 E:920 ||| CD
( ||| S:920 E:921 ||| -LRB-
1 ||| S:921 E:922 ||| LS
)  ||| S:922 E:924 ||| -RRB-
Clinical  ||| S:924 E:933 ||| NNP
and  ||| S:933 E:937 ||| CC
epidemiological  ||| S:937 E:953 ||| JJ
data ||| S:953 E:957 ||| NNS
:  ||| S:957 E:959 ||| :
Totally  ||| S:959 E:967 ||| RB
were  ||| S:967 E:972 ||| VBD
182  ||| S:972 E:976 ||| CD
children  ||| S:976 E:985 ||| NNS
with  ||| S:985 E:990 ||| IN
measles  ||| S:990 E:998 ||| NNS
( ||| S:998 E:999 ||| -LRB-
125  ||| S:999 E:1003 ||| CD
males ||| S:1003 E:1008 ||| NNS
,  ||| S:1008 E:1010 ||| ,
57  ||| S:1010 E:1013 ||| CD
females ||| S:1013 E:1020 ||| NNS
)  ||| S:1020 E:1022 ||| -RRB-
were  ||| S:1022 E:1027 ||| VBD
enrolled  ||| S:1027 E:1036 ||| VBN
into  ||| S:1036 E:1041 ||| IN
this  ||| S:1041 E:1046 ||| DT
study ||| S:1046 E:1051 ||| NN
.  ||| S:1051 E:1053 ||| .
The  ||| S:1053 E:1057 ||| DT
age  ||| S:1057 E:1061 ||| NN
of  ||| S:1061 E:1064 ||| IN
the  ||| S:1064 E:1068 ||| DT
patients  ||| S:1068 E:1077 ||| NNS
ranged  ||| S:1077 E:1084 ||| VBD
from  ||| S:1084 E:1089 ||| IN
3  ||| S:1089 E:1091 ||| CD
months  ||| S:1091 E:1098 ||| NNS
to  ||| S:1098 E:1101 ||| TO
89  ||| S:1101 E:1104 ||| CD
months ||| S:1104 E:1110 ||| NNS
,  ||| S:1110 E:1112 ||| ,
127  ||| S:1112 E:1116 ||| CD
cases  ||| S:1116 E:1122 ||| NNS
were  ||| S:1122 E:1127 ||| VBD
younger  ||| S:1127 E:1135 ||| JJR
than  ||| S:1135 E:1140 ||| IN
9  ||| S:1140 E:1142 ||| CD
months  ||| S:1142 E:1149 ||| NNS
( ||| S:1149 E:1150 ||| -LRB-
69.  ||| S:1150 E:1154 ||| CD
8 ||| S:1154 E:1155 ||| CD
% ||| S:1155 E:1156 ||| NN
) ||| S:1156 E:1157 ||| -RRB-
.  ||| S:1157 E:1159 ||| .
The  ||| S:1159 E:1163 ||| DT
prevalence  ||| S:1163 E:1174 ||| JJ
season  ||| S:1174 E:1181 ||| NN
was  ||| S:1181 E:1185 ||| VBD
from  ||| S:1185 E:1190 ||| IN
April  ||| S:1190 E:1196 ||| NNP
to  ||| S:1196 E:1199 ||| TO
August ||| S:1199 E:1205 ||| NNP
,  ||| S:1205 E:1207 ||| ,
while  ||| S:1207 E:1213 ||| IN
the  ||| S:1213 E:1217 ||| DT
peak  ||| S:1217 E:1222 ||| NN
month  ||| S:1222 E:1228 ||| NN
was  ||| S:1228 E:1232 ||| VBD
April  ||| S:1232 E:1238 ||| NNP
and  ||| S:1238 E:1242 ||| CC
May  ||| S:1242 E:1246 ||| NNP
( ||| S:1246 E:1247 ||| -LRB-
22.  ||| S:1247 E:1251 ||| CD
5 ||| S:1251 E:1252 ||| CD
% ||| S:1252 E:1253 ||| NN
,  ||| S:1253 E:1255 ||| ,
23.  ||| S:1255 E:1259 ||| CD
1 ||| S:1259 E:1260 ||| CD
% ||| S:1260 E:1261 ||| NN
) ||| S:1261 E:1262 ||| -RRB-
.  ||| S:1262 E:1264 ||| .
Among  ||| S:1264 E:1270 ||| IN
182  ||| S:1270 E:1274 ||| CD
hospitalized  ||| S:1274 E:1287 ||| CD
children ||| S:1287 E:1295 ||| NNS
,  ||| S:1295 E:1297 ||| ,
only  ||| S:1297 E:1302 ||| RB
11  ||| S:1302 E:1305 ||| CD
cases  ||| S:1305 E:1311 ||| NNS
underwent  ||| S:1311 E:1321 ||| VBD
measles  ||| S:1321 E:1329 ||| JJ
vaccination  ||| S:1329 E:1341 ||| NNS
( ||| S:1341 E:1342 ||| -LRB-
6.  ||| S:1342 E:1345 ||| CD
0 ||| S:1345 E:1346 ||| CD
% ||| S:1346 E:1347 ||| NN
) ||| S:1347 E:1348 ||| -RRB-
,  ||| S:1348 E:1350 ||| ,
and  ||| S:1350 E:1354 ||| CC
among  ||| S:1354 E:1360 ||| IN
them  ||| S:1360 E:1365 ||| PRP
5  ||| S:1365 E:1367 ||| CD
cases  ||| S:1367 E:1373 ||| NNS
were  ||| S:1373 E:1378 ||| VBD
within  ||| S:1378 E:1385 ||| IN
2  ||| S:1385 E:1387 ||| CD
weeks  ||| S:1387 E:1393 ||| NNS
before  ||| S:1393 E:1400 ||| IN
disease  ||| S:1400 E:1408 ||| NN
onset ||| S:1408 E:1413 ||| NN
.  ||| S:1413 E:1415 ||| .
A  ||| S:1415 E:1417 ||| DT
total  ||| S:1417 E:1423 ||| NN
of  ||| S:1423 E:1426 ||| IN
167  ||| S:1426 E:1430 ||| CD
cases  ||| S:1430 E:1436 ||| NNS
( ||| S:1436 E:1437 ||| -LRB-
91.  ||| S:1437 E:1441 ||| CD
8 ||| S:1441 E:1442 ||| CD
% ||| S:1442 E:1443 ||| NN
)  ||| S:1443 E:1445 ||| -RRB-
had  ||| S:1445 E:1449 ||| VBD
not  ||| S:1449 E:1453 ||| RB
been  ||| S:1453 E:1458 ||| VBN
vaccinated ||| S:1458 E:1468 ||| NN
,  ||| S:1468 E:1470 ||| ,
most  ||| S:1470 E:1475 ||| JJS
of  ||| S:1475 E:1478 ||| IN
whom  ||| S:1478 E:1483 ||| WP
were  ||| S:1483 E:1488 ||| VBD
immigrants ||| S:1488 E:1498 ||| NNS
,  ||| S:1498 E:1500 ||| ,
and  ||| S:1500 E:1504 ||| CC
the  ||| S:1504 E:1508 ||| DT
measles  ||| S:1508 E:1516 ||| JJ
vaccination  ||| S:1516 E:1528 ||| JJ
history  ||| S:1528 E:1536 ||| NN
of  ||| S:1536 E:1539 ||| IN
the  ||| S:1539 E:1543 ||| DT
remaining  ||| S:1543 E:1553 ||| JJ
4  ||| S:1553 E:1555 ||| CD
cases  ||| S:1555 E:1561 ||| NNS
were  ||| S:1561 E:1566 ||| VBD
unknown ||| S:1566 E:1573 ||| JJ
.  ||| S:1573 E:1575 ||| .
There  ||| S:1575 E:1581 ||| EX
was  ||| S:1581 E:1585 ||| VBD
a  ||| S:1585 E:1587 ||| DT
positive  ||| S:1587 E:1596 ||| JJ
correlation  ||| S:1596 E:1608 ||| NN
between  ||| S:1608 E:1616 ||| IN
the  ||| S:1616 E:1620 ||| DT
measles  ||| S:1620 E:1628 ||| JJ
vaccination  ||| S:1628 E:1640 ||| JJ
ratio  ||| S:1640 E:1646 ||| NN
in  ||| S:1646 E:1649 ||| IN
children  ||| S:1649 E:1658 ||| NNS
of  ||| S:1658 E:1661 ||| IN
the  ||| S:1661 E:1665 ||| DT
floating  ||| S:1665 E:1674 ||| JJ
population  ||| S:1674 E:1685 ||| NN
( ||| S:1685 E:1686 ||| -LRB-
8.  ||| S:1686 E:1689 ||| CD
45 ||| S:1689 E:1691 ||| CD
% ||| S:1691 E:1692 ||| NN
,  ||| S:1692 E:1694 ||| ,
6 ||| S:1694 E:1695 ||| CD
/ ||| S:1695 E:1696 ||| CD
71 ||| S:1696 E:1698 ||| CD
)  ||| S:1698 E:1700 ||| -RRB-
and  ||| S:1700 E:1704 ||| CC
the  ||| S:1704 E:1708 ||| DT
settled  ||| S:1708 E:1716 ||| JJ
children  ||| S:1716 E:1725 ||| NNS
( ||| S:1725 E:1726 ||| -LRB-
29.4 ||| S:1726 E:1730 ||| CD
% ||| S:1730 E:1731 ||| NN
,  ||| S:1731 E:1733 ||| ,
5 ||| S:1733 E:1734 ||| CD
/ ||| S:1734 E:1735 ||| CD
17 ||| S:1735 E:1737 ||| CD
,  ||| S:1737 E:1739 ||| ,
χ  ||| S:1739 E:1741 ||| CD
=8.  ||| S:1741 E:1745 ||| CD
11  ||| S:1745 E:1748 ||| CD
P  ||| S:1748 E:1750 ||| NN
=0.  ||| S:1750 E:1754 ||| CD
004 ||| S:1754 E:1757 ||| CD
) ||| S:1757 E:1758 ||| -RRB-
.  ||| S:1758 E:1760 ||| .
In  ||| S:1760 E:1763 ||| IN
total ||| S:1763 E:1768 ||| NN
,  ||| S:1768 E:1770 ||| ,
24  ||| S:1770 E:1773 ||| CD
cases  ||| S:1773 E:1779 ||| NNS
( ||| S:1779 E:1780 ||| -LRB-
13.  ||| S:1780 E:1784 ||| CD
2 ||| S:1784 E:1785 ||| CD
% ||| S:1785 E:1786 ||| NN
)  ||| S:1786 E:1788 ||| -RRB-
had  ||| S:1788 E:1792 ||| VBD
definite  ||| S:1792 E:1801 ||| JJ
measles  ||| S:1801 E:1809 ||| JJ
exposure  ||| S:1809 E:1818 ||| NN
history ||| S:1818 E:1825 ||| NN
,  ||| S:1825 E:1827 ||| ,
with  ||| S:1827 E:1832 ||| IN
153  ||| S:1832 E:1836 ||| CD
cases  ||| S:1836 E:1842 ||| NNS
( ||| S:1842 E:1843 ||| -LRB-
84.  ||| S:1843 E:1847 ||| CD
1 ||| S:1847 E:1848 ||| CD
% ||| S:1848 E:1849 ||| NN
)  ||| S:1849 E:1851 ||| -RRB-
of  ||| S:1851 E:1854 ||| IN
unknown  ||| S:1854 E:1862 ||| JJ
origin ||| S:1862 E:1868 ||| NN
, ||| S:1868 E:1869 ||| ,
5  ||| S:1869 E:1871 ||| CD
cases  ||| S:1871 E:1877 ||| NNS
( ||| S:1877 E:1878 ||| -LRB-
2.7 ||| S:1878 E:1881 ||| CD
% ||| S:1881 E:1882 ||| NN
)  ||| S:1882 E:1884 ||| -RRB-
without  ||| S:1884 E:1892 ||| IN
any  ||| S:1892 E:1896 ||| DT
history  ||| S:1896 E:1904 ||| NN
of  ||| S:1904 E:1907 ||| IN
contact.  ||| S:1907 E:1916 ||| NNP
( ||| S:1916 E:1917 ||| -LRB-
2 ||| S:1917 E:1918 ||| LS
)  ||| S:1918 E:1920 ||| -RRB-
Clinical  ||| S:1920 E:1929 ||| NNP
manifestations ||| S:1929 E:1943 ||| NNS
:  ||| S:1943 E:1945 ||| :
All  ||| S:1945 E:1949 ||| PDT
the  ||| S:1949 E:1953 ||| DT
182  ||| S:1953 E:1957 ||| CD
patients  ||| S:1957 E:1966 ||| NNS
had  ||| S:1966 E:1970 ||| VBD
fever  ||| S:1970 E:1976 ||| NN
( ||| S:1976 E:1977 ||| -LRB-
100 ||| S:1977 E:1980 ||| CD
% ||| S:1980 E:1981 ||| NN
)  ||| S:1981 E:1983 ||| -RRB-
and  ||| S:1983 E:1987 ||| CC
obvious  ||| S:1987 E:1995 ||| JJ
rashes  ||| S:1995 E:2002 ||| NNS
( ||| S:2002 E:2003 ||| -LRB-
100 ||| S:2003 E:2006 ||| CD
% ||| S:2006 E:2007 ||| NN
) ||| S:2007 E:2008 ||| -RRB-
,  ||| S:2008 E:2010 ||| ,
among  ||| S:2010 E:2016 ||| IN
them  ||| S:2016 E:2021 ||| PRP
145  ||| S:2021 E:2025 ||| CD
cases  ||| S:2025 E:2031 ||| NNS
had  ||| S:2031 E:2035 ||| VBD
body  ||| S:2035 E:2040 ||| NN
temperature  ||| S:2040 E:2052 ||| NN
higher  ||| S:2052 E:2059 ||| JJR
than  ||| S:2059 E:2064 ||| IN
39  ||| S:2064 E:2067 ||| CD
°C  ||| S:2067 E:2070 ||| CD
( ||| S:2070 E:2071 ||| -LRB-
79.  ||| S:2071 E:2075 ||| CD
7 ||| S:2075 E:2076 ||| CD
% ||| S:2076 E:2077 ||| NN
) ||| S:2077 E:2078 ||| -RRB-
.  ||| S:2078 E:2080 ||| .
The  ||| S:2080 E:2084 ||| DT
fever  ||| S:2084 E:2090 ||| NN
period  ||| S:2090 E:2097 ||| NN
ranged  ||| S:2097 E:2104 ||| VBD
from  ||| S:2104 E:2109 ||| IN
2  ||| S:2109 E:2111 ||| CD
to  ||| S:2111 E:2114 ||| TO
38  ||| S:2114 E:2117 ||| CD
days ||| S:2117 E:2121 ||| NNS
.  ||| S:2121 E:2123 ||| .
Among  ||| S:2123 E:2129 ||| IN
182  ||| S:2129 E:2133 ||| CD
hospitalized  ||| S:2133 E:2146 ||| CD
children ||| S:2146 E:2154 ||| NNS
, ||| S:2154 E:2155 ||| ,
165  ||| S:2155 E:2159 ||| CD
cases  ||| S:2159 E:2165 ||| NNS
( ||| S:2165 E:2166 ||| -LRB-
90.  ||| S:2166 E:2170 ||| CD
7 ||| S:2170 E:2171 ||| CD
% ||| S:2171 E:2172 ||| NN
)  ||| S:2172 E:2174 ||| -RRB-
had  ||| S:2174 E:2178 ||| VBD
typical  ||| S:2178 E:2186 ||| JJ
measles ||| S:2186 E:2193 ||| NN
, ||| S:2193 E:2194 ||| ,
17  ||| S:2194 E:2197 ||| CD
cases  ||| S:2197 E:2203 ||| NNS
had  ||| S:2203 E:2207 ||| VBD
atypical  ||| S:2207 E:2216 ||| JJ
measles ||| S:2216 E:2223 ||| NN
.  ||| S:2223 E:2225 ||| .
Among  ||| S:2225 E:2231 ||| IN
the  ||| S:2231 E:2235 ||| DT
17  ||| S:2235 E:2238 ||| CD
cases ||| S:2238 E:2243 ||| NNS
,  ||| S:2243 E:2245 ||| ,
two  ||| S:2245 E:2249 ||| CD
had  ||| S:2249 E:2253 ||| VBD
severe  ||| S:2253 E:2260 ||| JJ
measles ||| S:2260 E:2267 ||| NN
,  ||| S:2267 E:2269 ||| ,
one  ||| S:2269 E:2273 ||| PRP
had  ||| S:2273 E:2277 ||| VBD
heterotypic  ||| S:2277 E:2289 ||| CD
measles.  ||| S:2289 E:2298 ||| CD
( ||| S:2298 E:2299 ||| -LRB-
3 ||| S:2299 E:2300 ||| LS
)  ||| S:2300 E:2302 ||| -RRB-
The  ||| S:2302 E:2306 ||| DT
common  ||| S:2306 E:2313 ||| JJ
complica  ||| S:2313 E:2322 ||| JJ
tions ||| S:2322 E:2327 ||| NN
:  ||| S:2327 E:2329 ||| :
96  ||| S:2329 E:2332 ||| CD
cases  ||| S:2332 E:2338 ||| NNS
had  ||| S:2338 E:2342 ||| VBD
pneumonia  ||| S:2342 E:2352 ||| NNS
( ||| S:2352 E:2353 ||| -LRB-
52.  ||| S:2353 E:2357 ||| CD
8 ||| S:2357 E:2358 ||| CD
% ||| S:2358 E:2359 ||| NN
) ||| S:2359 E:2360 ||| -RRB-
,  ||| S:2360 E:2362 ||| ,
80  ||| S:2362 E:2365 ||| CD
had  ||| S:2365 E:2369 ||| VBD
laryngitis  ||| S:2369 E:2380 ||| NNS
( ||| S:2380 E:2381 ||| -LRB-
44.  ||| S:2381 E:2385 ||| CD
0 ||| S:2385 E:2386 ||| CD
% ||| S:2386 E:2387 ||| NN
) ||| S:2387 E:2388 ||| -RRB-
,  ||| S:2388 E:2390 ||| ,
38  ||| S:2390 E:2393 ||| CD
had  ||| S:2393 E:2397 ||| VBD
bronchitis  ||| S:2397 E:2408 ||| NNS
( ||| S:2408 E:2409 ||| -LRB-
20.  ||| S:2409 E:2413 ||| CD
9 ||| S:2413 E:2414 ||| CD
% ||| S:2414 E:2415 ||| NN
) ||| S:2415 E:2416 ||| -RRB-
, ||| S:2416 E:2417 ||| ,
15  ||| S:2417 E:2420 ||| CD
had  ||| S:2420 E:2424 ||| VBD
hepatic  ||| S:2424 E:2432 ||| JJ
dysfunction  ||| S:2432 E:2444 ||| NNS
( ||| S:2444 E:2445 ||| -LRB-
8.  ||| S:2445 E:2448 ||| CD
2 ||| S:2448 E:2449 ||| CD
% ||| S:2449 E:2450 ||| NN
) ||| S:2450 E:2451 ||| -RRB-
,  ||| S:2451 E:2453 ||| ,
11  ||| S:2453 E:2456 ||| CD
had  ||| S:2456 E:2460 ||| VBD
myocardial  ||| S:2460 E:2471 ||| JJ
damage  ||| S:2471 E:2478 ||| NN
( ||| S:2478 E:2479 ||| -LRB-
6.  ||| S:2479 E:2482 ||| CD
0 ||| S:2482 E:2483 ||| CD
% ||| S:2483 E:2484 ||| NN
) ||| S:2484 E:2485 ||| -RRB-
,  ||| S:2485 E:2487 ||| ,
3  ||| S:2487 E:2489 ||| CD
had  ||| S:2489 E:2493 ||| VBD
febrile  ||| S:2493 E:2501 ||| JJ
seizures  ||| S:2501 E:2510 ||| NNS
( ||| S:2510 E:2511 ||| -LRB-
1.  ||| S:2511 E:2514 ||| CD
6 ||| S:2514 E:2515 ||| CD
% ||| S:2515 E:2516 ||| NN
) ||| S:2516 E:2517 ||| -RRB-
,  ||| S:2517 E:2519 ||| ,
and  ||| S:2519 E:2523 ||| CC
no  ||| S:2523 E:2526 ||| DT
patient  ||| S:2526 E:2534 ||| NN
had  ||| S:2534 E:2538 ||| VBD
encephalitis ||| S:2538 E:2550 ||| VBN
.  ||| S:2550 E:2552 ||| .
Of  ||| S:2552 E:2555 ||| IN
the  ||| S:2555 E:2559 ||| DT
96  ||| S:2559 E:2562 ||| CD
cases  ||| S:2562 E:2568 ||| NNS
with  ||| S:2568 E:2573 ||| IN
pneumonia ||| S:2573 E:2582 ||| NN
,  ||| S:2582 E:2584 ||| ,
92  ||| S:2584 E:2587 ||| CD
received  ||| S:2587 E:2596 ||| VBD
sputum  ||| S:2596 E:2603 ||| JJ
test ||| S:2603 E:2607 ||| NN
;  ||| S:2607 E:2609 ||| :
38  ||| S:2609 E:2612 ||| CD
were  ||| S:2612 E:2617 ||| VBD
sputum  ||| S:2617 E:2624 ||| JJ
culture  ||| S:2624 E:2632 ||| NN
positive  ||| S:2632 E:2641 ||| JJ
( ||| S:2641 E:2642 ||| -LRB-
41 ||| S:2642 E:2644 ||| CD
% ||| S:2644 E:2645 ||| NN
) ||| S:2645 E:2646 ||| -RRB-
.  ||| S:2646 E:2648 ||| .
The  ||| S:2648 E:2652 ||| DT
dominant  ||| S:2652 E:2661 ||| JJ
pathogens  ||| S:2661 E:2671 ||| NN
were  ||| S:2671 E:2676 ||| VBD
Streptococcus  ||| S:2676 E:2690 ||| JJ
pneumoniae ||| S:2690 E:2700 ||| NNS
( ||| S:2700 E:2701 ||| -LRB-
11 ||| S:2701 E:2703 ||| CD
/ ||| S:2703 E:2704 ||| CD
38,29 ||| S:2704 E:2709 ||| CD
% ||| S:2709 E:2710 ||| NN
) ||| S:2710 E:2711 ||| -RRB-
,  ||| S:2711 E:2713 ||| ,
Haemophilus  ||| S:2713 E:2725 ||| NNP
influenzae  ||| S:2725 E:2736 ||| NNS
( ||| S:2736 E:2737 ||| -LRB-
6 ||| S:2737 E:2738 ||| CD
/  ||| S:2738 E:2740 ||| CD
38,16 ||| S:2740 E:2745 ||| CD
% ||| S:2745 E:2746 ||| NN
) ||| S:2746 E:2747 ||| -RRB-
,  ||| S:2747 E:2749 ||| ,
Moraxella  ||| S:2749 E:2759 ||| NNP
catarrhalis  ||| S:2759 E:2771 ||| NNS
( ||| S:2771 E:2772 ||| -LRB-
4 ||| S:2772 E:2773 ||| CD
/ ||| S:2773 E:2774 ||| CD
38 ||| S:2774 E:2776 ||| CD
,  ||| S:2776 E:2778 ||| ,
11 ||| S:2778 E:2780 ||| CD
% ||| S:2780 E:2781 ||| NN
) ||| S:2781 E:2782 ||| -RRB-
,  ||| S:2782 E:2784 ||| ,
Escherichia  ||| S:2784 E:2796 ||| NNP
coli  ||| S:2796 E:2801 ||| NNS
( ||| S:2801 E:2802 ||| -LRB-
4 ||| S:2802 E:2803 ||| CD
/ ||| S:2803 E:2804 ||| CD
38 ||| S:2804 E:2806 ||| CD
,  ||| S:2806 E:2808 ||| ,
11 ||| S:2808 E:2810 ||| CD
% ||| S:2810 E:2811 ||| NN
) ||| S:2811 E:2812 ||| -RRB-
,  ||| S:2812 E:2814 ||| ,
Candida  ||| S:2814 E:2822 ||| NNP
albicans  ||| S:2822 E:2831 ||| NNS
( ||| S:2831 E:2832 ||| -LRB-
4 ||| S:2832 E:2833 ||| CD
/ ||| S:2833 E:2834 ||| CD
38 ||| S:2834 E:2836 ||| CD
,  ||| S:2836 E:2838 ||| ,
11 ||| S:2838 E:2840 ||| CD
% ||| S:2840 E:2841 ||| NN
) ||| S:2841 E:2842 ||| -RRB-
,  ||| S:2842 E:2844 ||| ,
Mycoplasma  ||| S:2844 E:2855 ||| NNP
pneumoniae  ||| S:2855 E:2866 ||| NNS
( ||| S:2866 E:2867 ||| -LRB-
4 ||| S:2867 E:2868 ||| CD
/ ||| S:2868 E:2869 ||| CD
38 ||| S:2869 E:2871 ||| CD
,  ||| S:2871 E:2873 ||| ,
11 ||| S:2873 E:2875 ||| CD
% ||| S:2875 E:2876 ||| NN
)  ||| S:2876 E:2878 ||| -RRB-
and  ||| S:2878 E:2882 ||| CC
Staphylococcus  ||| S:2882 E:2897 ||| NNP
aureus  ||| S:2897 E:2904 ||| NNS
( ||| S:2904 E:2905 ||| -LRB-
3 ||| S:2905 E:2906 ||| CD
/ ||| S:2906 E:2907 ||| CD
38 ||| S:2907 E:2909 ||| CD
,  ||| S:2909 E:2911 ||| ,
8 ||| S:2911 E:2912 ||| CD
% ||| S:2912 E:2913 ||| NN
) ||| S:2913 E:2914 ||| -RRB-
.  ||| S:2914 E:2916 ||| .
( ||| S:2916 E:2917 ||| -LRB-
4 ||| S:2917 E:2918 ||| LS
)  ||| S:2918 E:2920 ||| -RRB-
The  ||| S:2920 E:2924 ||| DT
H1a  ||| S:2924 E:2928 ||| CD
genotype  ||| S:2928 E:2937 ||| NNS
was  ||| S:2937 E:2941 ||| VBD
the  ||| S:2941 E:2945 ||| DT
only  ||| S:2945 E:2950 ||| RB
one  ||| S:2950 E:2954 ||| CD
genotype  ||| S:2954 E:2963 ||| NN
in  ||| S:2963 E:2966 ||| IN
the  ||| S:2966 E:2970 ||| DT
detected  ||| S:2970 E:2979 ||| JJ
sequence  ||| S:2979 E:2988 ||| NN
of  ||| S:2988 E:2991 ||| IN
54  ||| S:2991 E:2994 ||| CD
measles  ||| S:2994 E:3002 ||| JJ
virus  ||| S:3002 E:3008 ||| NN
strains ||| S:3008 E:3015 ||| NNS
.  ||| S:3015 E:3017 ||| .
Measles  ||| S:3017 E:3025 ||| NNP
was  ||| S:3025 E:3029 ||| VBD
more  ||| S:3029 E:3034 ||| RBR
often  ||| S:3034 E:3040 ||| RB
seen  ||| S:3040 E:3045 ||| VBN
in  ||| S:3045 E:3048 ||| IN
the  ||| S:3048 E:3052 ||| DT
children  ||| S:3052 E:3061 ||| NNS
under  ||| S:3061 E:3067 ||| IN
the  ||| S:3067 E:3071 ||| DT
age  ||| S:3071 E:3075 ||| NN
of  ||| S:3075 E:3078 ||| IN
9  ||| S:3078 E:3080 ||| CD
months  ||| S:3080 E:3087 ||| NNS
from  ||| S:3087 E:3092 ||| IN
the  ||| S:3092 E:3096 ||| DT
floating  ||| S:3096 E:3105 ||| JJ
population ||| S:3105 E:3115 ||| NN
.  ||| S:3115 E:3117 ||| .
The  ||| S:3117 E:3121 ||| DT
morbidity  ||| S:3121 E:3131 ||| JJ
peak  ||| S:3131 E:3136 ||| NN
month  ||| S:3136 E:3142 ||| NN
was  ||| S:3142 E:3146 ||| VBD
from  ||| S:3146 E:3151 ||| IN
April  ||| S:3151 E:3157 ||| NNP
to  ||| S:3157 E:3160 ||| TO
May  ||| S:3160 E:3164 ||| NNP
in  ||| S:3164 E:3167 ||| IN
Shanghai ||| S:3167 E:3175 ||| NNP
.  ||| S:3175 E:3177 ||| .
The  ||| S:3177 E:3181 ||| DT
H1a  ||| S:3181 E:3185 ||| CD
genotype  ||| S:3185 E:3194 ||| NNS
was  ||| S:3194 E:3198 ||| VBD
the  ||| S:3198 E:3202 ||| DT
only  ||| S:3202 E:3207 ||| RB
one  ||| S:3207 E:3211 ||| CD
genotype ||| S:3211 E:3219 ||| NNS
.  ||| S:3219 E:3221 ||| .
We  ||| S:3221 E:3224 ||| PRP
should  ||| S:3224 E:3231 ||| MD
try  ||| S:3231 E:3235 ||| VB
to  ||| S:3235 E:3238 ||| TO
improve  ||| S:3238 E:3246 ||| VB
vaccination  ||| S:3246 E:3258 ||| JJ
coverage  ||| S:3258 E:3267 ||| NN
rate  ||| S:3267 E:3272 ||| NN
in  ||| S:3272 E:3275 ||| IN
the  ||| S:3275 E:3279 ||| DT
children  ||| S:3279 E:3288 ||| NNS
who  ||| S:3288 E:3292 ||| WP
are  ||| S:3292 E:3296 ||| VBP
at  ||| S:3296 E:3299 ||| IN
the  ||| S:3299 E:3303 ||| DT
age  ||| S:3303 E:3307 ||| NN
for  ||| S:3307 E:3311 ||| IN
vaccination ||| S:3311 E:3322 ||| NN
,  ||| S:3322 E:3324 ||| ,
so  ||| S:3324 E:3327 ||| RB
as  ||| S:3327 E:3330 ||| RB
to  ||| S:3330 E:3333 ||| TO
prevent  ||| S:3333 E:3341 ||| VB
measles  ||| S:3341 E:3349 ||| JJ
outbreak ||| S:3349 E:3357 ||| NN
.  ||| S:3357 E:3359 ||| .
